Ligand · MY9
MY9 · N-{(1S,2S)-1-benzyl-2-hydroxy-2-[(4S)-1,2,2-trimethyl-5-oxoimidazolidin-4-yl]ethyl}-N'-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]isophthalamide
MY9, N-{(1S,2S)-1-benzyl-2-hydroxy-2-[(4S)-1,2,2-trimethyl-5-oxoimidazolidin-4-yl]ethyl}-N'-[(1R)-1-(4-fluorophenyl)ethyl]-5-[methyl(methylsulfonyl)amino]isophthalamide (C33 H40 F N5 O6 S, 653.8 g/mol), in the MolNFT structures on…
- Component
- MY9
- Formula
- C33 H40 F N5 O6 S
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
MY9 in 2 structures; the first of them:
- 2P8H · Crystal structure of human beta secretase complexed with inhibitor · MY9 A386 · binds GLY11, GLN12, GLY13, TYR14, LEU30, ASP32, GLY34, SER35 and 22 more
- 2P8H · Crystal structure of human beta secretase complexed with inhibitor · MY9 A386 · binds GLY11, GLN12, GLY13, TYR14, LEU30, ASP32, GLY34, SER35 and 22 more
Residues it binds most
GLY 2, ILE 2, SER 2, THR 2, TYR 2, ARG 2, ASP 2, GLN 2, ALA 2, ASN 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.